If VHT can show contracts in the coming quarters in both these new jurisdictions (Taiwan & Japan) then I think market will stand up and see the global potential.
I like that the two new areas are ones where technological advancement and uptake seem IMP to be greater that the USA and could faster become the ‘normal’.
IMO There is the potential for an additional CR toward the end of next year based on cash burn. I read an article in the NBR (sorry can’t paste except) but the sentiment is that the directors want Valpara to grow market share and be a leader in breast imaging rather than turn a profit in the short term. This I see being a hinderance in the SP. however I thought the same about XRO, and I was dead wrong there
VHT Price at posting:
69.0¢ Sentiment: Buy Disclosure: Held
